Keywords
Treatment in PCOS
Insulin resistance
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To identify the therapies used in the treatment of Polycystic Ovarian Syndrome (PCOS) discussed in the scientific community, as a way to help in the therapeutic choice. Methods: An integrative bibliographic review of the literature, through an active search in the Virtual Health Library, U.S National Library of Medicine and the National Institutes Health and EBSCOHost databases, using two Health Science Descriptors in English, plus the operator boolean, AND << “Polycystic Ovary Syndrome” AND Therapeutics >>, published in the last five years and with full text. Results: The final sample, composed of 33 articles, showed a predominance of publications from Egypt and China, in EBSCOHost and prospective clinical studies. As for treatment, Letrozole for infertility, dietary intervention and modulation of the intestinal microbiota for hyperandrogenism, and Metformin for the metabolic changes present in PCOS were identified. Final considerations: The therapies used in the treatment of polycystic ovary syndrome should be according to the individual complaint of the patient and their effectiveness, the most studied being Letrozole, dietary intervention, modulation of the intestinal microbiota and Metformin.
References
ABBARA A, et al. Kisspeptin receptor agonist has therapeutic potential for female reproductive disorders. The Journal of clinical investigation, 2020; 130(12): e6739-6753.
ABU HASHIM H, et al. Unilateral or bilateral laparoscopic ovarian drilling in polycystic ovary syndrome: a meta-analysis of randomized trials. Archives of Gynecology and Obstetrics, 2018; 297(4): e859-870.
ACMAZ G, et al. The effects of oral isotretinoin in women with acne and polycystic ovary syndrome. BioMed research international, 2019; 2019(1): e1-5.
AHMED A, et al. Clomiphene citrate and metformin" stair step" protocol vs. traditional protocol in patients with polycystic ovary syndrome" PCOS". Egyptian Journal of Hospital Medicine, 2018; 72(5): e4463-4468.
AKINOSO-IMRAN AQ e ADETUNJI H. Systematic review and meta-analysis of letrozole and clomiphene citrate in polycystic ovary syndrome. Middle East Fertility Society Journal, 2018; 23(3): e163-170.
ALKOUDSI KT, et al. A. Assessing the effectiveness of a pharmaceutical care service on the quality of life of women with polycystic ovarian syndrome living in war and non-war countries. J Eval Clin Pract, 2020; 26(5): e1467-1477.
ALOBAIDI MT, et al. Impact of letrozole versus clomiphene citrate on endometrial receptivity in Iraqi women with polycystic ovarian syndrome. Journal of Clinical Pharmacy and Therapeutics, 2019; 44(4): e618-622.
ALTINOK ML, et al. Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome. Gynecological Endocrinology, 2018; (34)10: e859-863.
ARENTZ S, et al. Combined lifestyle and herbal medicine in overweight women with polycystic ovary syndrome (PCOS): a randomized controlled trial. Phytotherapy research, 2017; 31(9): e1330-1340.
CENA H, et al. Obesity, polycystic ovary syndrome, and infertility: a new avenue for GLP-1 receptor agonists. The Journal of Clinical Endocrinology & Metabolism, 2020; 105(8): e2695-2709.
CHE X, et al. Dietary Interventions: A Promising Treatment for Polycystic Ovary Syndrome. Annals of Nutrition and Metabolism, 2021; 77(6): e313-323.
D’AMATO G, et al. Mild ovarian stimulation with letrozole plus fixed dose human menopausal gonadotropin prior to IVF/ICSI for infertile non-obese women with polycystic ovarian syndrome being pre-treated with metformin: a pilot study. Reproductive Biology and Endocrinology, 2018; 16(1): e1-8.
EL FAHAM D, et al. Can Amlodipine Improve the Pre-ovulatory Follicle Blood Flow in Women with Polycystic Ovarian Syndrome? Journal of Reproduction & Infertility, 2019; 20(2): e89.
FRUZZETTI F, et al. Treatment with d-chiro-inositol and alpha lipoic acid in the management of polycystic ovary syndrome. Gynecological Endocrinology, 2019; 35(6): e506-510.
FURAT RENCBER S, et al. Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study. Journal of ovarian research, 2018; 11(1): e1-16.
GADALLA MA, et al. Medical and surgical treatment of reproductive outcomes in polycystic ovary syndrome: an overview of systematic reviews. International journal of fertility & sterility, 2020; 13(4): e257.
GU Y, et al. Gut and Vaginal Microbiomes in PCOS: Implications for Women’s Health. Frontiers in Endocrinology, 2022; 13(1): e1-9.
HU K, et al. Advances in clinical applications of kisspeptin-GnRH pathway in female reproduction. Reproductive Biology and Endocrinology, 2022; 20(1): e1-20.
JIN P e XIE Y. Treatment strategies for women with polycystic ovary syndrome. Gynecological Endocrinology, 2018; 34(4): e272-277.
JONAS CF. Uso terapêutico de mio-inositol como tratamento em pacientes com síndrome do ovário policístico. UFRGS, 2019; 1(1): e1-41.
KAMAL D, et al. Beneficial effects of green tea catechins on female reproductive disorders: A review. Molecules, 2021; 26(9): e2675.
KAMBOJ MK e BONNY AE. Polycystic ovary syndrome in adolescence: diagnostic and therapeutic strategies. Translational pediatrics, 2017; 6(4): e248.
LAGANÀ AS, et al. Myo-inositol supplementation reduces the amount of gonadotropins and length of ovarian stimulation in women undergoing IVF: a systematic review and meta-analysis of randomized controlled trials. Archives of Gynecology and Obstetrics, 2018; 298(4): e675-684.
MEIER RK. Polycystic ovary syndrome. Nursing Clinics, 2018; 53(3): e407-420.
MELO AEF, et al. Benefícios do uso de metformina em pacientes com síndrome dos ovários policísticos. Revista Ciência & Desenvolvimento, 2019; 12(3): e502-519.
MOKHTARI F, et al. Effects of melatonin administration on chemical pregnancy rates of polycystic ovary syndrome patients undergoing intrauterine insemination: a randomized clinical trial. International journal of fertility & sterility, 2019; 13(3): e225.
NASRI K, et al. The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. BMC Endocrine Disorders, 2018; 18(1): 1-8.
PATHMANATHAN S, et al. A Case of Successful Treatment with Unilateral Oophorectomy in a Patient with Resistant Polycystic Ovary Syndrome. Case Reports in Endocrinology, 2020; 2020(1): e1-6.
QI X, et al. Gut microbiota–bile acid–interleukin-22 axis orchestrates polycystic ovary syndrome. Nature medicine, 2019; 25(8): e1225-1233.
RAHMANI E, et al. The effects of fish oil on gene expression in patients with polycystic ovary syndrome. European journal of clinical investigation, 2018; 48(3): e12893.
REGIDOR P, et al. Chronic inflammation in PCOS: the potential benefits of specialized pro-resolving lipid mediators (SPMs) in the improvement of the resolutive response. International Journal of Molecular Sciences, 2020; 22(1): e384.
ROSA-E-SILVA AC. Conceito, epidemiologia e fisiopatologia aplicada à prática clínica. In: Síndrome dos ovários policísticos. Federação Brasileira das Associações de Ginecologia e Obstetrícia, 2018; 2018(1): e1-15.
SACHDEVA G, et al. Prediction of responsiveness to clomiphene citrate in infertile women with PCOS. Journal of Reproduction & Infertility, 2019; 20(3): e143.
SHAMASBI SG, et al. The effect of resistant dextrin as a prebiotic on metabolic parameters and androgen level in women with polycystic ovarian syndrome: a randomized, triple-blind, controlled, clinical trial. European journal of nutrition, 2019; 58(2): e629-640.
SHARMA S, et al. Efficacy of metformin in the treatment of acne in women with polycystic ovarian syndrome: a newer approach to acne therapy. The Journal of clinical and aesthetic dermatology, 2019; 12(5): e34.
SKORUPSKAITE K, et al. Kisspeptin and neurokinin B interactions in modulating gonadotropin secretion in women with polycystic ovary syndrome. Human Reproduction, 2020; 35(6): e1421.
SOUSA LMM, et al. A metodologia de revisão integrativa da literatura em enfermagem. Revista Investigação em Enfermagem, 2017; 17(2): e17-26.
SOUSA MNA. Revisão integrativa da literatura: esclarecendo o método. Medicina e Pesquisa, 2016; 1(1): e345-358.
YAMAN FK e ARSLAN S. Effects of progesterone treatment in polycystic ovary syndrome on pulmonary functions. Türk Hijyen ve Deneysel Biyoloji Dergisi, 2019; 76(2): e203-210.
ZAHRAN KM, et al. Clomiphene citrate plus cabergoline versus clomiphene citrate for induction of ovulation in infertile euprolactinemic patients with polycystic ovary syndrome: A randomized clinical trial. Middle East Fertility Society Journal, 2018; 23(3): e173-177.